Introduction {#S1}
============

Plasmids of IncA and IncC incompatibility groups have been combined into IncA/C since 1970s, but IncA and IncC groups are essentially compatible ([@B2]) and have significant nucleotide divergence across their backbones ([@B20]) and, thus, IncA \[reference plasmid pRA1 ([@B16])\] and IncC should be separated from IncA/C ([@B21]). IncC plasmids have two distinct types, namely, type 1 and type 2 ([@B19]), which are represented by reference plasmids pR148 ([@B12]), and pR55 ([@B4]), respectively. These two types can be distinguished by two genes of substitution (*orf1832* in type 1 or *orf1847* in type 2, and *rhs1* in type 1 or *rhs2* in type 2) and two small intergenic insertions (i1 and i2 found in type 2 rather than type 1) ([@B19]).

A large array of antibiotic resistance genes have been found in IncC plasmids and are clustered in various accessory modules inserted at various sites of the IncC backbones ([@B20]). IncC plasmids contain at least three hotspots for integration of the *bla*~CMY~-carrying region and two [a]{.ul}ntibiotic [r]{.ul}esistance [i]{.ul}slands designated ARI-A and ARI-B. The *bla*~CMY~-carrying region and ARI-A are frequently found in type 1 plasmids but not type 2; both type 1 and type 2 plasmids carry ARI-B, but this island is not always present in these plasmids ([@B20]).

Our previous study ([@B27]) has shown considerable genomic variation in a collection of three type 1 IncC plasmids from China together with pR148. This follow-up study presents the complete nucleotide sequences of 11 new IncC plasmids from China and a further comprehensive genomic comparison of these 11 plasmids together with pR148 and pR55, providing a deeper insight into parallel evolution of IncC plasmids from China.

Materials and Methods {#S2}
=====================

Bacterial Strains {#S2.SS1}
-----------------

The 11 isolates ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}) were recovered from the sputum or blood specimens of 11 different patients with nosocomial infections in 10 Chinese public hospitals from 2012 to 2016. Bacterial species identification was performed using genome sequence-based average nucleotide identity analysis ([@B35]).

Conjugal Transfer {#S2.SS2}
-----------------

Plasmid conjugal transfer experiments were carried out with rifampin-resistant *Escherichia coli* EC600 or sodium azide-resistant *E. coli* J53 being used as a recipient and each of the QD1501, A2293, and 205880 isolates as a donor. Three milliliters of overnight cultures of each of donor and recipient bacteria were mixed together, harvested, and resuspended in 80 μl of Brain Heart Infusion (BHI) broth (BD Biosciences). The mixture was spotted on a 1 cm^2^ hydrophilic nylon membrane filter with a 0.45 μm pore size (Millipore) that was placed on a BHI agar (BD Biosciences) plate and then incubated for mating at 37°C for 12 to 18 h. Bacteria were washed from filter membrane and spotted on Muller-Hinton (MH) agar (BD Biosciences) plates, for selecting an *E. coli* transconjugant carrying *bla*~NDM~ (pQD1501-Ct1), *bla*~CTX--M~ (pA2293-Ct2), or *bla*~CMY~ (p205880-Ct1/2). 200 μg/ml sodium azide (for J53) or 1000 μg/ml rifampin (for EC600), together with 4 μg/ml imipenem (for *bla*~NDM~) or 200 μg/ml ampicillin (for *bla*~CTX--M~ or *bla*~CMY~), was for *E. coli* transconjugant selection.

Sequencing and Sequence Assembly {#S2.SS3}
--------------------------------

Genomic DNA was isolated from each of the above 11 isolates using an UltraClean Microbial Kit (Qiagen, NW, Germany). The genomic DNA of strains 427113, T5282, and 397108 was sequenced from mate-pair libraries with an average insert size of 5 kb (ranging from 2 to 10 kb) using a MiSeq sequencer (Illumina, CA, United States) and DNA contigs were assembled based on their contig coverages using *Newbler* 2.6 ([@B29]). Quality control, removing adapters, and low quality reads were performed using *Trimmomatic* 0.36 ([@B6]). The filtered clean reads were then assembled using *Newbler* 2.6 ([@B29]), followed by extraction of the consensus sequence with *CLC Genomics Workbench* 3.0 (Qiagen Bioinformatics). *Gapfiller* V1.11 ([@B5]) was used for gap closure. For all the other eight isolates, genome sequencing was performed with a sheared DNA library with an average size of 15 kb (ranging from 10 to 20 kb) on a PacBio RSII sequencer (Pacific Biosciences, CA, United States), as well as a paired-end library with an average insert size of 400 bp (ranging from 150 to 600 kb) on a HiSeq sequencer (Illumina, CA, United States). The paired-end short Illumina reads were used to correct the long PacBio reads utilizing *proovread* ([@B18]), and then the corrected PacBio reads were assembled *de novo* utilizing *SMARTdenovo*^[1](#footnote1){ref-type="fn"}^.

Sequence Annotation and Comparison {#S2.SS4}
----------------------------------

Open reading frames (ORFs) and pseudogenes were predicted using *RAST* 2.0 ([@B9]) combined with *BLASTP/BLASTN* ([@B7]) searches against the *UniProtKB/Swiss-Prot* database ([@B8]) and the *RefSeq* database ([@B31]). Annotation of resistance genes, mobile elements, and other features was carried out using the online databases including *CARD* ([@B22]), *ResFinder* ([@B40]), *ISfinder* ([@B38]), *INTEGRALL* ([@B28]), and *Tn Number Registry* ([@B36]). Multiple and pairwise sequence comparisons were performed using *MUSCLE* 3.8.31 ([@B14]) and *BLASTN*, respectively. Gene organization diagrams were drawn in *Inkscape* 0.48.1^[2](#footnote2){ref-type="fn"}^. Heatmaps were plotted with *MeV* 4.9.0 ([@B37]).

Phylogenetic Analysis {#S2.SS5}
---------------------

The backbone regions of indicative plasmids were aligned using *MUMmer* 3.0 ([@B25]). Inference of homologous recombination was performed using *ClonalFrameML* ([@B13]) to remove recombination-associated single-nucleotide polymorphisms (SNPs). A maximum-likelihood tree was constructed from recombination-free SNPs using *MEGA7* ([@B24]) with a bootstrap iteration of 1000.

Antimicrobial Susceptibility Testing {#S2.SS6}
------------------------------------

Bacterial antimicrobial susceptibility was tested by BioMérieux VITEK 2 and interpreted as per the 2017 Clinical and Laboratory Standards Institute (CLSI) guidelines ([@B11]).

Nucleotide Sequence Accession Numbers {#S2.SS7}
-------------------------------------

The complete nucleotide sequences of plasmids [p24845-Ct2](p24845-Ct2), [p205880-Ct1/2](p205880-Ct1/2), [pT5282-Ct2](pT5282-Ct2), [pKpn47-Ct1/2](pKpn47-Ct1/2), [p11935-Ct1/2](p11935-Ct1/2), [pQD1501-Ct1](pQD1501-Ct1), [p12085-Ct1](p12085-Ct1), [pA2293-Ct2](pA2293-Ct2), [p397108-Ct2](p397108-Ct2), [p427113-Ct1/2](p427113-Ct1/2), and [pA1763-Ct2](pA1763-Ct2) were submitted to GenBank under the accession numbers [MF344572](MF344572) to [MF344574](MF344574), [MN310369](MN310369), [MN310375](MN310375), [MN310377](MN310377), [MN310378](MN310378), [MH917284](MH917284), [MH917285](MH917285), and [MG764552](MG764552), respectively.

Results {#S3}
=======

Overview of Sequenced IncC Plasmids {#S3.SS1}
-----------------------------------

Of the 11 IncC plasmids fully sequenced in this work ([Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}), two and five could be assigned into type 1 and type 2, respectively, based on the presence or absence of *orf1832*/*orf1847*, *rhs1*/*rhs2*, i1, and i2, while the remaining four, containing *orf1832* and *rhs1* (characteristic of type 1) plus i2 (characteristic of type 2), were recognized as type 1/2 hybrid. A total of 597 core SNPs (among them 69 were recombination-free) were identified from the backbone regions of these 11 plasmids together with type 1 reference pR148 and type 2 reference pR55. As shown in the phylogenetic tree ([Figure 1A](#F1){ref-type="fig"}) constructed from the 69 recombination-free SNPs, these 13 plasmids could be clustered into three separate clades, corresponding to the above three subtypes. A pairwise sequence comparison using *BLASTN* showed that these 13 plasmids displayed \>99% nucleotide identity across ≥50% of their backbone sequences within each of subgroup IncC plasmids, and had \>97% nucleotide identity across ≥47% of their backbone sequences between different subgroups ([Figure 1B](#F1){ref-type="fig"} and [Supplementary Table S2](#TS2){ref-type="supplementary-material"}). The above results confirmed a parallel diversification and evolution of type 1, type 2, and type 1/2-hybrid IncC plasmids. These 13 plasmids varied in size from about 90 kb to nearly 206 kb with variation in the number of predicted ORFs from 118 to 246, and each plasmid was dissected into the IncC backbone regions and the accessory modules, which were defined as acquired DNA regions associated and bordered with mobile elements ([Table 2](#T2){ref-type="table"} and [Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). These 13 plasmids shared common IncC backbone genes *repA*, *parAB*, *tra2*, *dcm2*, *yacC*, *int*, *kfrA*, and *uvrD*.

###### 

Type 1, 2, and 1/2-hybrid plasmids analyzed.

  **IncC subtype**   **Plasmid**     **Accession number**   ***orf1832/orf1847***   ***rhs1/rhs2***   **i1**   **i2**   **Host bacterium**             **Location**   **References**
  ------------------ --------------- ---------------------- ----------------------- ----------------- -------- -------- ------------------------------ -------------- ----------------
  Type 1 reference   pR148           JX141473               *orf1832*               *rhs1*            *−*      *−*      *Aeromonas hydrophila*         Thailand       [@B12]
  Type 1             pQD1501-Ct1     MN310375               *orf1832*               *Δrhs1*           *−*      *−*      *Klebsiella quasipneumoniae*   China          This study
  Type 1             p12085-Ct1      MN310377               \-                      *Δrhs1*           *−*      *−*      *K. pneumoniae*                China          This study
  Type 2 reference   pR55            JQ010984               *orf1847*               *rhs2*            \+       \+       *K. pneumoniae*                France         [@B4]
  Type 2             pA2293-Ct2      MN310378               *orf1847*               *Δrhs2*           \+       \+       *K. pneumoniae*                China          This study
  Type 2             pA1763-Ct2      MG764552               \-                      *Δrhs2*           \+       \+       *K. pneumoniae*                China          This study
  Type 2             p24845-Ct2      MF344572               *orf1847*               *Δrhs2*           \+       \+       *Enterobacter hormaechei*      China          This study
  Type 2             p397108-Ct2     MH917284               \-                      *rhs2*            \+       *−*      *K. pneumoniae*                China          This study
  Type 2             pT5282-Ct2      MF344574               *orf1847*               *rhs2*            −        \+       *E. hormaechei*                China          This study
  Type 1/2 hybrid    p205880-Ct1/2   MF344573               *orf1832*               *rhs1*            −        \+       *K. pneumoniae*                China          This study
  Type 1/2 hybrid    p427113-Ct1/2   MH917285               *orf1832*               *rhs1*            −        \+       *K. pneumoniae*                China          This study
  Type 1/2 hybrid    pKpn47-Ct1/2    MN310369               *orf1832*               *rhs1*            −        \+       *K. pneumoniae*                China          This study
  Type 1/2 hybrid    p11935-Ct1/2    MN310370               *orf1832*               *rhs1*            −        \+       *K. pneumoniae*                China          This study
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###### 

Major features of analyzed IncC plasmids.

  **Plasmid**      **Total length (bp)**   **Total number of ORFs**   **Mean G + C content (%)**   **Length of backbone (bp)**   **Mean G + C content of backbone (%)**   **Accessory modules**                                                                                                         
  ---------------- ----------------------- -------------------------- ---------------------------- ----------------------------- ---------------------------------------- ----------------------- ----- ------------------------------------- --------------------------------------------------------- --------------------------------------------
  pR148            165,906                 195                        52.5                         127,803                       51.2                                     Tn*6358*                −     --                                    --                                                        --
  pQD1501--Ct1     132,407                 161                        51.9                         113,444                       51.2                                     \+                      −     Tn*6538b*                             --                                                        --
  p12085--Ct1      90,252                  122                        51.7                         79,675                        51.1                                     −                       −     *bla*~CMY--6~*--bla*~NDM--1~ region   *−*                                                       *−*
  pR55             170,810                 203                        53.0                         129,210                       51.2                                     *−*                     \+    *−*                                   Tn*6187*                                                  *−*
  pA2293--Ct2      181,726                 205                        51.0                         124,622                       51.1                                     *−*                     \+    *−*                                   *−*                                                       IS*Kpn52*:IS*30*, IS*As25*, and IS*100kyp*
  pA1763--Ct2      93,441                  118                        51.2                         67,327                        51.0                                     *−*                     \+    *−*                                   *bla*~CTX--M--3~ region                                   *−*
  p24845--Ct2      167,619                 192                        49.9                         89,202                        51.0                                     *−*                     *−*   *−*                                   MDR region                                                ΔTn*6292--*ΔIS*26--*IS*26* region
  p397108--Ct2     105,977                 133                        52.5                         64,665                        50.7                                     *−*                     \+    *−*                                   Tn*6558*                                                  IS*Kpn18*
  pT5282--Ct2      152,215                 173                        52.8                         94,867                        51.2                                     *−*                     \+    *−*                                   *bla*~CTX--M--14~*--bla*~IMP--8~ region, and MDR region   IS*Ehe3*, and IS*Ehe3*
  p205880--Ct1/2   153,373                 182                        52.3                         117,240                       51.2                                     Tn*6395*                \+    Tn*6538a*                             *−*                                                       *−*
  p427113--Ct1/2   205,674                 246                        53.3                         116,457                       51.3                                     \+                      \+    Tn*6538a*                             MDR region                                                *−*
  pKpn47--Ct1/2    154,204                 178                        52.4                         116,460                       51.3                                     \+                      \+    Tn*6538c*                             *−*                                                       IS*Kpn18*, IS*1R*, and IS*Kpn18*
  p11935--Ct1/2    154,204                 181                        52.5                         116,459                       51.3                                     \+                      \+    Tn*6538c*                             *−*                                                       IS*Kpn18*, IS*1R*, and IS*Kpn18*

+, presence ARI-A or ARI-B, but not identified as an intact transposon; --, absence.

![Evolutionary relationships of IncC plasmids. **(A)** A maximum-likelihood phylogenetic tree. The tree is constructed from recombination-free SNPs of core backbone regions. The degree of support (percentage) for each cluster of associated taxa, as determined by bootstrap analysis, is shown next to each branch. The bar corresponds to the scale of sequence divergence. Triangles indicate the references for type 1 and type 2 IncC plasmids. **(B)** A heatmap of pairwise comparison of plasmid backbone sequences. The original BLAST coverage and nucleotide identity values are shown in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}.](fmicb-10-02508-g001){#F1}

Major Modular Differences in Backbone and Accessory Regions {#S3.SS2}
-----------------------------------------------------------

At least seven major modular differences were identified across the whole plasmid sequences ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure S2](#FS2){ref-type="supplementary-material"}). First, two small regions (*dsbA--orf429*, and *orf858--orf192/orf189--nuc*) displayed \<95% nucleotide identity between all the three type 1 plasmids and all the 10 type 1/2-hybrid and type 2 plasmids, for which a gene substitution (*orf192* in the former three, and *orf189* in the later ten) occurred. Second, the ARI-B island or the ΔTn*6292--*ΔIS*26--*IS*26* region was inserted into the backbone *dcm1* region of all the 10 type 1/2-hybrid and type 2 plasmids, leading to a 4.5- to 11.0-kb deletion within the *dcm1* region of these 10 plasmids expect for pR55. Third, the three type 1 plasmids had a backbone gene *orf489* showing \<90% nucleotide identity to all the other plasmids; IS*Kpn18* was inserted at a site within the backbone gene *orf501* in p397108-Ct2, resulting in a 60.1-kb deletion (containing the whole *tra1* region and the *dcm3* region). Fourth, compared to the prototype *tra1* region as observed in pR148 and additional two plasmids, various insertions of accessory modules were found in the other plasmids: (i) Tn*6538a* or Tn*6538b* or Tn*6538c* or the *bla*~CMY--6~*--bla*~NDM--1~ region was inserted downstream of *tivF1* of all the seven type 1 and type 1/2-hybrid plasmids except for pR148, resulting in a 48.1-kb deletion in p12085-Ct1; (ii) the insertion of IS*Ehe3* into *orf672* of pT5282-Ct2 or that of *bla*~CTX--M--3~ region into *rlx* of pA1763-Ct2 led to a 24.5-kb or 57.4-kb deletion, respectively; and (iii) IS*Kpn18* plus IS*1R* was inserted into *tivF6* of pKpn47-Ct1/2 or p11935-Ct1/2, while the MDR (multidrug resistance) region was inserted into the same gene of p427113-Ct1/2 or p24845-Ct2, leading to a 35.5-kb deletion in p24845-Ct2. Fifth, the backbone *dcm3* region was completely or partially lost in five plasmids, which was caused by accessory module insertion or other unknown reasons. Sixth, the ARI-A island was inserted into the backbone gene *orf240* of all the seven type 1 and type 1/2-hybrid plasmids except for p12085-Ct1, while IS*Kpn52*:IS*30* plus IS*As25* was inserted into a type 2 plasmid pA2293-Ct2. Seventh, Tn*6187*, IS*100kyp* and Tn*6558* were inserted at different sites around the backbone *ter* gene of pR55, pA2293-Ct2, and p397108-Ct2, respectively; additionally, three separate insertions of the MDR region, the *bla*~CTX--M--14~*--bla*~IMP--8~ region, and the IS*Ehe3* element into the backbone *ter--*to*--tivF3* region made its segmentation in pT5282-Ct2.

![Major modular differences among IncC plasmids. Genes are denoted by arrows. Genes, mobile elements, and other features are colored based on function classification. Shading denotes regions of homology (≥95% nucleotide identity).](fmicb-10-02508-g002){#F2}

ARI-A and ARI-B Islands {#S3.SS3}
-----------------------

As found in all the seven type 1 and type 1/2-hybrid plasmids except for p12085-Ct1 (type 1), the ARI-A islands ([Figure 3](#F3){ref-type="fig"}) were identified as Tn*1696* ([@B32]) derivatives. The Tn*1696* derivatives in pR148 and p205880-Ct1/2 were recognized as intact unit transposons Tn*6358* ([@B27]) and Tn*6395*, respectively, which differed from Tn*1696* mainly by insertion of In834 ([@B27]) and In1212 instead of In4 into a primary *tnpAR*--*mer* structure. The Tn*1696* derivatives in the other four plasmids could not be discriminated as intact transposons due to 3′-terminal truncations, which were in some cases accompanied with insertion of additional resistance modules: *bla*~NDM--1~-carrying ΔTn*125* ([@B34]) in pQD1501-Ct1 and *strAB*-carrying ΔTn*6029* ([@B10]) in p427113-Ct1/2.

![Organization of ARI-A islands and comparison to related regions. Genes are denoted by arrows. Genes, mobile elements, and other features are colored based on their functional classification. Shading denotes regions of homology (nucleotide identity ≥95%). Numbers in brackets indicate nucleotide positions within corresponding plasmids. The accession numbers of Tn*1696* ([@B32]), Tn*125* ([@B34]), Tn*1721* ([@B1]), and Tn*6029* ([@B10]) for reference are U12338, JN872328, X61367, and HQ840942, respectively.](fmicb-10-02508-g003){#F3}

The ARI-B islands ([Figure 4](#F4){ref-type="fig"}) were found in all the 10 type 2 and type 1/2-hybrid plasmids except for p24845-Ct2 (type 2), and all of them contained a *sul2* gene that was originated from either GI*sul2* ([@B30]) or Tn*6029* ([@B10]), because various *sul2*-carrying remnants of GI*sul2* or Tn*6029* were found in these ARI-B islands. In general, these ARI-B islands acquired dramatically different collection of resistance modules, which contained genes resistance to older (such as *dfrA*, *strAB*, *tetA*, and *floR*) and newer (such as *bla*~CTX--M~, *armA*, *msr*, and *mph*) antibiotics, and thus varied considerably in size with a highly mosaic nature. The ΔTn*6292--*ΔIS*26--*IS*26* region ([Figure 4](#F4){ref-type="fig"}), which did not contain any of resistance genes, was inserted at the site specific for ARI-B insertion.

![Organization of ARI-B islands and comparison to related regions. Genes are denoted by arrows. Genes, mobile elements, and other features are colored based on their functional classification. Shading denotes regions of homology (nucleotide identity ≥95%). Numbers in brackets indicate nucleotide positions within corresponding plasmids. The accession numbers of Tn*1696* ([@B32]), Tn*1548* ([@B17]), *aacC2*--*tmrB* region ([@B33]), Tn*7* (see [@B41], for gene organization), Tn*2* ([@B3]), Tn*6029* ([@B10]), GI*sul2* ([@B30]), Tn*6292* ([@B39]), and Tn*1722* ([@B1]) for reference are [U12338](U12338), [AF550415](AF550415), [JX101693](JX101693), [KX117211](KX117211), [HM749967](HM749967), [HQ840942](HQ840942), [AE014073](AE014073), [KU886034](KU886034), and [X61367](X61367), respectively.](fmicb-10-02508-g004){#F4}

Other Accessory Resistance Modules {#S3.SS4}
----------------------------------

Four different *bla*~CMY~-carrying regions ([Figure 5](#F5){ref-type="fig"}) were found in all the seven type 1 and type 1/2-hybrid plasmids except for pR148 and were manifested as three intact IS*Ecp1*-based transposition units Tn*6538a* (p205880-Ct1/2 and p427113-Ct1/2), Tn*6538b* (pQD1501-Ct1), and Tn*6538c* (pKpn47-Ct1/2 and p11935-Ct1/2), and the *bla*~CMY--6~*--bla*~NDM--1~ region (p12085-Ct1). Tn*6538a*, Tn*6538b*, and Tn*6538c* were highly similar to one another but differed by substitution of *bla*~CMY--2~ with *bla*~CMY--6~ or by insertion of IS*1R* into IS*Ecp1*. The *bla*~CMY--6~*--bla*~NDM--1~ region was a combination of ΔTn*6538b* carrying *bla*~CMY--6~, IS*Kpn14*, and ΔTn*125* containing *bla*~NDM--1~.

![Organization of *bla*~CMY~-carrying regions and comparison to related regions. Genes are denoted by arrows. Genes, mobile elements and other features are colored based on their functional classification. Shading denotes regions of homology (nucleotide identity ≥95%). Numbers in brackets indicate nucleotide positions within corresponding plasmids. The accession number of Tn*125* ([@B34]) for reference is JN872328.](fmicb-10-02508-g005){#F5}

Four different *bla*~CTX--M~-carrying regions were found in four type 2 plasmids: Tn*6558* (p397108-Ct2), the *bla*~CTX--M--14~*--bla*~IMP--8~ region (pT5282-Ct2), and the *bla*~CTX--M--3~ region (pA1763-Ct2) ([Figure 6](#F6){ref-type="fig"}), as well as the ARI-B island (pA2293-Ct2) ([Figure 4](#F4){ref-type="fig"}). Insertion of a truncated version of Tn*6503*, which was an IS*Ecp1*-based, *bla*~CTX--M--14~-carrying transposition unit ([@B15]), into the cryptic unit transposon Tn*1722* generated Tn*6558*, while the *bla*~CTX--M--14~*--bla*~IMP--8~ region was resulted from three separate insertions of Tn*6503*, In655 (carrying *bla*~IMP--8~), and IS*26* into Tn*1722*. The *bla*~CTX--M--3~ region in pA1763-Ct2 was highly similar to a partial region of the ARI-B island in pA2293-Ct2, and both carried the IS*Ecp1*-based *bla*~CTX--M--3~-carrying transposition unit Tn*6502* ([@B26]).

![Organization of *bla*~CTX--M~-carrying regions and comparison to related regions. Genes are denoted by arrows. Genes, mobile elements and other features are colored based on their functional classification. Shading denotes regions of homology (nucleotide identity ≥95%). Numbers in brackets indicate nucleotide positions within corresponding plasmids. The accession numbers of Tn*1722* ([@B1]), Tn*6292* ([@B39]) and Tn*1696* ([@B32]) for reference are [X61367](X61367), [KU886034](KU886034) and [U12338](U12338), respectively.](fmicb-10-02508-g006){#F6}

Four different MDR regions ([Figure 7](#F7){ref-type="fig"}) were found in four plasmids: Tn*6187* ([@B4]) in pR55, and three MDR regions in p427113-Ct1/2, pT5282-Ct2, and p24845-Ct2. As similar to the above ARI-B islands, different MDR regions were assembled from different collections of resistance units \[especially including ΔTn*6296* carrying *bla*~KPC--2~, IS*26*--*mph*(A)--*mrx*--*mphR*(A)--IS*6100* unit, In207, In384, and *rmtB*--*tetA*(G)--*tetR*(G)--*floR* region\] via homologous or non-homologous recombination.

![Organization of MDR regions and comparison to related regions. Genes are denoted by arrows. Genes, mobile elements and other features are colored based on their functional classification. Shading denotes regions of homology (nucleotide identity ≥95%). Numbers in brackets indicate nucleotide positions within corresponding plasmids. The accession number of Tn*1696* ([@B32]), Tn*21* ([@B32]), Tn*1548* ([@B17]), Tn*2* ([@B3]), *aacC2*--*tmrB* region ([@B33]) and Tn*6296* ([@B23]) for reference are [U12338](U12338), [AF071413](AF071413), [AF550415](AF550415), [HM749967](HM749967), [JX101693](JX101693) and [FJ628167](FJ628167), respectively.](fmicb-10-02508-g007){#F7}

Transferability and Antimicrobial Susceptibility {#S3.SS5}
------------------------------------------------

Plasmids pQD1501-Ct1, pA2293-Ct2, and p205880-Ct1/2 were arbitrarily selected as the representatives of type 1, type 2, and type 1/2 hybrid, respectively, and could be transferred from the wild-type isolates into J53 or EC600 through conjugation, generating *E*. *coli* transconjugants QD1501-NDM-J53, A2293-CTXM-J53, and 205880-CMY-EC600, respectively. The self-transferable nature was consistent with the presence of two complete sets (*tra1* and *tra2*) of conjugal transfer genes in each plasmid, although Tn*6538a* or Tn*6538b* was inserted at an intergenic site in *tra1* of p205880-Ct1/2 or pQD1501-Ct1, respectively. All the three wild-type isolates QD1501, A2293, and 205880 and one transconjugant QD1501-NDM-J53 were resistant to imipenem with minimum inhibitory concentration (MIC) values ≥16 (due to production of NDM or KPC enzyme) but the other two transconjugants A2293-CTXM-J53 and 205880-CMY-EC600 remained susceptible to imipenem. All the above strains were resistant to cefuroxime with MIC values ≥32 (due to production of NDM or CTX-M or CMY enzyme).

Discussion {#S4}
==========

Comparative genomics analysis of the collection of IncC plasmids (*n* = 13 in this study) provides a deeper understanding of diversification of IncC plasmids. Different IncC plasmids have evolved to acquire very different profiles of accessory modules and thus different collections of resistance genes ([Figure 8](#F8){ref-type="fig"}). Insertion of accessory modules is often accompanied by deletion of surrounding backbone regions. Type 1/2-hybrid IncC plasmids most likely emerged from homologous recombination between type 1 and type 2 plasmids. In addition to using the presence or absence of signature sequences *orf1832*/*orf1847*, *rhs1*/*rhs2*, i1, and i2, a phylogenetic analysis using recombination-free SNPs of core backbone regions can steadily discriminate type 1/2 hybrid from type 1 and type 2. As shown previously ([@B27]) and herein, additional resistance islands (e.g., the MDR regions and the *bla*~CTX--M~-carrying regions in this study) can be found in type 1, type 2, and type 1/2-hybrid plasmids.

![A heatmap of prevalence of resistance genes in IncC plasmids. The original data are shown in [Supplementary Table S3](#TS3){ref-type="supplementary-material"}.](fmicb-10-02508-g008){#F8}

The IncC reference plasmids pR148 (166 kb in length, 195 ORFs) and pR55 (171 kb in length, 203 ORFs) had the most complete backbones for type 1 and type 2, respectively. By contrast, the type 1 plasmid p12085-Ct1 and the type 2 plasmids pA1763-Ct2 and p397108-Ct2 harbored extremely simple backbones due to deletion of large backbone regions. In addition to insertion of accessory modules and deletion of backbone regions, large inversion (such as those in p427113-Ct1/2 and pA1763-Ct2) and translocation (such as those in pT5282-Ct2) events occurred within backbone regions during genomic diversification of IncC plasmids ([@B27]; [Supplementary Figure S2](#FS2){ref-type="supplementary-material"}).

The carbapenemase genes *bla*~NDM--1~, *bla*~KPC--2~, and *bla*~IMP--8~ were identified in pQD1501-Ct1 and p12085-Ct1, p427113-Ct1/2, and pT5282-Ct2, respectively. This is the first report of a *bla*~IMP--8~-carrying IncC plasmid. This study presents three novel mobile elements \[firstly identified in this study, including Tn*6395* (p205880-Ct1/2), In2-76 (pA1763-Ct2), and IS*Ecl10* (p24845-Ct2)\] and additionally six newly named mobile elements \[firstly designated in this study but with previously determined sequences, including Tn*6538a* (p205880-Ct1/2 and p427113-Ct1/2), Tn*6538b* (pQD1501-Ct1), Tn*6538c* (pKpn47-Ct1/2 and p11935-Ct1/2), Tn*6502* (pA2293-Ct2 and pA1763-Ct2), Tn*6503* (pT5282-Ct2), and IS*Kpn52* (pA2293-Ct2)\].
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